Leave Your Message
Explore our flagship medicated and silver-ion sanitary pads engineered for active therapeutic intervention, bacterial vaginosis treatment, and daily protective hygiene.
The global feminine hygiene industry is undergoing a monumental paradigm shift. For decades, the primary function of sanitary pads was limited to basic fluid absorption and leakage prevention. However, as global health awareness rises and biotechnology intersects with personal care, consumers are demanding products that do more. The market is transitioning rapidly toward healthier menstrual care solutions that actively promote gynecological wellness, maintain microecological balance, and prevent or treat infections.
During menstruation, the vaginal microenvironment undergoes significant changes. The presence of menstrual blood alters the natural pH balance, rendering the environment less acidic and making it highly susceptible to the overgrowth of pathogenic bacteria. This susceptibility often leads to common gynecological conditions such as Bacterial Vaginosis (BV), yeast infections, and vulvovaginitis. Consequently, integrating active antimicrobial agents, such as silver ions and bio-medicated herbal formulas, into sanitary pads has emerged as a key industrial and clinical solution.
According to global market research, the functional and organic sanitary pad segment is projected to grow at a CAGR of over 8.5% over the next decade. Demand is heavily driven by medical-grade certifications, scientific backing, and natural antibacterial efficacy.
Historically, mass-market consumer packaged goods (CPG) brands dominated the feminine care space with standardized plastic-based products. Today, specialized pharmaceutical manufacturers are capturing significant market share by developing medical-grade sanitary pads. These companies operate cleanroom facilities that meet stringent medical device standards (such as ISO 13485), bringing pharmaceutical rigor to everyday personal care products.
From a commercial standpoint, business-to-business (B2B) procurement channels, including hospitals, gynecological clinics, pharmacies, and specialized e-commerce platforms, are prioritizing functional pads. Distributors and sourcing agents are moving away from price-war commoditized pads and shifting focus to high-margin, value-added therapeutic pads. The integration of patented technologies, such as silver-ion delivery systems, ensures high customer retention rates due to observable clinical benefits.
Several innovative trends are redefining the design and manufacturing of sanitary pads for healthier menstrual care:
Silver ions exert a broad-spectrum antibacterial effect by disrupting bacterial cell membranes and inhibiting DNA replication, providing an effective barrier against BV-causing pathogens.
Eliminating synthetic plastics and chlorine bleaching. Utilizing organic cotton and highly breathable bottom films reduces heat and moisture accumulation, which prevents anaerobic bacterial proliferation.
Functional and medicated sanitary pads are not merely replacement products for standard pads; they serve as targeted solutions across several distinct gynecological and lifestyle scenarios. Understanding these application scenarios allows medical professionals and distributors to better serve their target markets.
Bacterial Vaginosis is characterized by a depletion of beneficial lactobacilli and an overgrowth of anaerobic organisms like Gardnerella vaginalis. While oral or topical antibiotics are standard treatments, recurrence rates remain high. Medicated and silver-ion pads serve as an excellent adjuvant therapy. By continuously releasing antimicrobial agents during menstruation (when recurrence risk is highest), these pads suppress pathogens and help maintain a healthy microbial balance without interfering with systemic health.
Following childbirth, women experience lochia discharge for several weeks. During this postpartum phase, the cervix remains slightly dilated, and the uterine lining is healing, creating an extremely vulnerable pathway for ascending infections. Using standard, non-sterile, plastic-heavy sanitary pads can trap heat and pathogens, increasing the risk of endometritis or perineal wound infections. Silver-ion gynecological pads provide a sterile, highly breathable, and actively antibacterial environment that supports safe postpartum recovery.
Many women suffer from chronic, low-grade gynecological discomfort, itching, or abnormal discharge due to lifestyle factors, such as prolonged sitting, high-stress levels, or humid climates. Incorporating active antibacterial pads into their routine—particularly in the days immediately preceding and following the menstrual cycle—acts as a proactive shield. It prevents transient pathogens from establishing localized infections, providing peace of mind and physical comfort.
Menstrual odor is primarily caused by the breakdown of blood proteins by bacteria in a warm, moist environment. Standard deodorizing pads often rely on synthetic fragrances that can cause contact dermatitis. Antibacterial pads solve this issue at the source: by preventing bacterial growth, they naturally eliminate odor without the use of irritating artificial perfumes, making them ideal for active women, athletes, and those with sensitive skin.
Founded in 1995, Shaanxi Wanan Pharmaceutical Co., Ltd is a modern Pharmaceutical enterprise incorporating with science research, production and sales. With a fixed assets of about RMB 65 million Yuan (About USD 8 million) and an annual sales volume of over RMB 50 million Yuan ( About USD 6 million), Wanan Pharmaceutical has currently over 300 employees, 50% of which are medical professionals, including a scientific research group consisting of 5 medical doctors and 11 masters, an expert group consisting of more than 70 gynecological doctors.
Zimeishu silver-ion gynecological pad is Wanan’s major product and has prominent effect on preventing and treating gynecological inflammations. It has passed ISO 9001: 2000, the international quality standard and ISO13485:2003, the international medical equipment standard. Now, the sales network has stretched to most large and medium cities in China and has won favors of female over 6 million.
By operating at the intersection of pharmaceutical science and daily personal care, Shaanxi Wanan Pharmaceutical Co., Ltd. has established a high barrier to entry in the feminine hygiene market. The integration of a dedicated expert group consisting of 70 gynecological doctors ensures that product development is guided by clinical needs and verified through strict scientific protocols.
Passing the international medical equipment standard ISO 13485:2003 is a testament to the company's rigorous manufacturing controls. Unlike standard consumer goods factories, medical device manufacturers must adhere to strict cleanroom classifications, comprehensive bio-burden testing, and complete traceability of raw materials. This ensures that every Zimeishu pad is free from contaminants and delivers consistent therapeutic performance.
With a mature domestic sales network that has served over 6 million women, Shaanxi Wanan Pharmaceutical is actively expanding its international footprint. The factory offers robust OEM and ODM services for global brands looking to introduce medicated or silver-ion pads into their portfolios.
From custom packaging designs to proprietary formulation adjustments, Wanan's research team supports global distributors in navigating local regulatory approvals. By partnering with a certified pharmaceutical factory, international brands can confidently market their products with verified health claims, avoiding the regulatory pitfalls associated with uncertified sanitary pads.
Understanding the mechanism of silver ions is essential to appreciating why they represent a breakthrough for healthier menstrual care. Silver (Ag) has been used as a natural antimicrobial agent for centuries. In modern medicine, nano-silver technology allows for the controlled release of silver ions (Ag+), which are highly active against a broad spectrum of microorganisms.
Importantly, silver-ion pads from Shaanxi Wanan are designed for localized, non-systemic action. The active ingredients remain embedded within the functional layer of the pad, exerting their antibacterial effect upon contact with moisture (menstrual fluid or sweat). This localized action ensures that the natural internal vaginal flora is not disrupted, maintaining the delicate balance of the vaginal microbiome.
Select from our comprehensive portfolio of medical-grade sanitary pads, optimized for clinical distribution, pharmaceutical retail, and direct consumer health solutions.